Hereditary Angioedema

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria New Drug Evaluation
C1 esterase inhibitor BERINERT KIT Y PA Document  
C1 esterase inhibitor BERINERT VIAL Y PA Document  
C1 esterase inhibitor HAEGARDA VIAL Y PA Document  
berotralstat hydrochloride ORLADEYO CAPSULE N PA Document  
C1 esterase inhibitor CINRYZE VIAL N PA Document  
C1 esterase inhibitor, recomb RUCONEST VIAL N PA Document  
ecallantide KALBITOR VIAL N PA Document  
icatibant acetate FIRAZYR SYRINGE N PA Document  
icatibant acetate ICATIBANT SYRINGE N PA Document  
icatibant acetate SAJAZIR SYRINGE N PA Document  
lanadelumab-flyo TAKHZYRO SYRINGE N PA Document  
lanadelumab-flyo TAKHZYRO VIAL N PA Document